Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Nilsson

Showing results (281-290 of 288) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 288 results.
Frontiers in Immunology|September 28, 2020
Thirty-Eight-Negative Kinase 1 Is a Mediator of Acute Kidney Injury in Experimental and Clinical Traumatic Hemorrhagic ShockRebecca Halbgebauer, Ebru Karasu, Christian K Braun, et al.
Clinical Immunology (Orlando, Fla.)|September 16, 2018
Safety profile after prolonged C3 inhibitionEdimara S Reis, Nadja Berger, Xin Wang, et al.
Nature Immunology|September 29, 2019
'Stealth' corporate innovation: an emerging threat for therapeutic drug developmentDimitrios C Mastellos, Anna M Blom, E Sander Connolly, et al.
Nature Immunology|October 13, 2019
Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug developmentDimitrios C Mastellos, Anna M Blom, E Sander Connolly, et al.
Clinical Immunology (Orlando, Fla.)|September 22, 2020
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacyDimitrios C Mastellos, Bruno G P Pires da Silva, Benedito A L Fonseca, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 22, 2022
Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's SyndromeChristian Lundtoft, Christopher Sjöwall, Solbritt Rantapää-Dahlqvist, et al.
Science Advances|August 17, 2022
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101Panagiotis Skendros, Georgios Germanidis, Dimitrios C Mastellos, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2022
Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune DiseasesChristian Lundtoft, Pascal Pucholt, Myriam Martin, et al.
Pageof 29

Showing results (281-290 of 288) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 288 results.
Frontiers in Immunology|September 28, 2020
Thirty-Eight-Negative Kinase 1 Is a Mediator of Acute Kidney Injury in Experimental and Clinical Traumatic Hemorrhagic ShockRebecca Halbgebauer, Ebru Karasu, Christian K Braun, et al.
Clinical Immunology (Orlando, Fla.)|September 16, 2018
Safety profile after prolonged C3 inhibitionEdimara S Reis, Nadja Berger, Xin Wang, et al.
Nature Immunology|September 29, 2019
'Stealth' corporate innovation: an emerging threat for therapeutic drug developmentDimitrios C Mastellos, Anna M Blom, E Sander Connolly, et al.
Nature Immunology|October 13, 2019
Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug developmentDimitrios C Mastellos, Anna M Blom, E Sander Connolly, et al.
Clinical Immunology (Orlando, Fla.)|September 22, 2020
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacyDimitrios C Mastellos, Bruno G P Pires da Silva, Benedito A L Fonseca, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 22, 2022
Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's SyndromeChristian Lundtoft, Christopher Sjöwall, Solbritt Rantapää-Dahlqvist, et al.
Science Advances|August 17, 2022
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101Panagiotis Skendros, Georgios Germanidis, Dimitrios C Mastellos, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2022
Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune DiseasesChristian Lundtoft, Pascal Pucholt, Myriam Martin, et al.
Pageof 29